| 000 | 01822 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513120023.0 | ||
| 264 | 0 | _c19970612 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCook, J J | |
| 245 | 0 | 0 |
_aNonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cMay 1997 |
||
| 300 |
_a677-89 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine Diphosphate _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAzepines _xadministration & dosage |
| 650 | 0 | 4 | _aBleeding Time |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDrug Administration Routes |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMacaca mulatta |
| 650 | 0 | 4 | _aPan troglodytes |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 |
_aThrombosis _xprevention & control |
| 700 | 1 | _aSitko, G R | |
| 700 | 1 | _aHolahan, M A | |
| 700 | 1 | _aStranieri, M T | |
| 700 | 1 | _aGlass, J D | |
| 700 | 1 | _aAskew, B C | |
| 700 | 1 | _aMcIntyre, C J | |
| 700 | 1 | _aClaremon, D A | |
| 700 | 1 | _aBaldwin, J J | |
| 700 | 1 | _aHartman, G D | |
| 700 | 1 | _aGould, R J | |
| 700 | 1 | _aLynch, J J | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 281 _gno. 2 _gp. 677-89 |
|
| 999 |
_c9133670 _d9133670 |
||